Loading clinical trials...
Loading clinical trials...
Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer
Conditions
Interventions
FMISO-PET Scan
Chemoradiation
+2 more
Locations
9
United States
Hartford Healthcare (Data Collection Only)
Hartford, Connecticut, United States
Baptist Alliance MCI (Data Collection Only)
Miami, Florida, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)
Commack, New York, United States
Start Date
August 19, 2024
Primary Completion Date
August 1, 2027
Completion Date
August 1, 2027
Last Updated
April 23, 2026
NCT04988074
NCT05639972
NCT04900623
NCT03795610
NCT05608369
NCT05582590
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions